Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX) trades at $0.069 with AI Score 49/100 (Grade C). Zicix Corporation, through its subsidiary Texas Mobile Health, provides diagnostic medical imaging services in Houston, Texas. Sector: Technology.
Price as of Aug 21, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for ZICX: ZICX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ZICX against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ZICX: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX) Technology Profile & Competitive Position
Zicix Corporation operates in the technology sector, focusing on diagnostic medical imaging services through its subsidiary Texas Mobile Health, providing essential healthcare solutions in Houston, Texas, with a commitment to innovative medical diagnostics.
What Is the Investment Thesis for ZICX?
Zicix Corporation presents a unique investment thesis characterized by its specialized focus on diagnostic medical imaging services, which are critical in today's healthcare landscape. The company's gross margin stands at 35.6%, indicating a potential for profitability improvement as it scales operations. With the increasing demand for diagnostic services, driven by an aging population and advancements in medical technology, Zicix is well-positioned to capture market share in Houston and potentially expand its services. The company's current market cap of $0.01 billion reflects its nascent stage, with significant growth potential as it enhances its service offerings. However, the company faces challenges, including a negative profit margin of -138.0%, which underscores the need for operational efficiencies and revenue growth initiatives to achieve sustainable profitability. Investors should monitor the company's strategic initiatives and market dynamics closely to assess its growth trajectory.
Based on FMP financials and quantitative analysis
ZICX Key Highlights
Market Cap of $0.01B reflects the company's early-stage growth potential in the healthcare technology sector.
- Gross Margin of 35.6% indicates a reasonable level of profitability for its service offerings.
- Negative Profit Margin of -138.0% highlights the need for operational improvements and revenue growth strategies.
- Beta of 1.53 suggests higher volatility compared to the market, indicating potential investment risk.
- No dividend yield reflects the company's focus on reinvestment for growth rather than returning capital to shareholders.
Who Are ZICX's Competitors?
ZICX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| IFNNF Infineon Technologies AG | $63.00 | -0.24% | $82.0B | 49 |
| CNSWF Constellation Software Inc. | $2233.27 | +0.73% | $47.3B | 53 |
| XYZ Block, Inc. | $80.08 | -1.05% | $47.7B | 73 |
| NIPNF NEC Corporation | $30.50 | +0.00% | $40.5B | — |
| ADYEY Adyen N.V. | $12.35 | +0.73% | $39.0B | 52 |
| RSASF RESAAS Services Inc. | $0.31 | +6.90% | $26.1M | 69 |
| IDN Intellicheck, Inc. | $2.96 | -3.10% | $60.0M | 78 |
| WFCF Where Food Comes From, Inc. | $13.05 | +4.40% | $65.8M | 71 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ZICX's Key Strengths?
Established reputation in Houston for diagnostic medical imaging services.
- Diverse range of medical services catering to various patient needs.
- Strong focus on cardiac diagnostics, a critical healthcare area.
- Ability to leverage advanced imaging technologies for improved patient care.
What Are ZICX's Weaknesses?
Limited workforce with only two employees, restricting operational capacity.
- Negative profit margin indicating financial challenges.
- Small market cap may limit access to capital for expansion.
- Dependence on local market conditions in Houston.
What Could Drive ZICX Stock Higher?
Expansion of diagnostic services to include advanced cardiac care.
- Development of telehealth services to enhance patient accessibility.
- Strategic partnerships with local healthcare providers to increase patient referrals.
- Investment in AI-driven imaging technologies to improve diagnostic accuracy.
- Marketing campaigns aimed at increasing brand awareness in Houston.
What Are the Key Risks for ZICX?
Financial-distress signal — its Altman Z-Score of -7.15 sits in the distress zone (elevated bankruptcy risk).
- Economic downturns affecting patient spending on healthcare services.
- Intense competition from established healthcare providers and imaging centers.
- Regulatory changes impacting service delivery and operational costs.
- Dependence on local market conditions in Houston for revenue generation.
What Are the Growth Opportunities for ZICX?
- Expansion of Diagnostic Services: Zicix Corporation can enhance its service offerings by expanding its diagnostic capabilities, particularly in cardiac care. The cardiac diagnostic market is projected to grow significantly, with an estimated value of $20 billion by 2027. By investing in advanced imaging technology and expanding its service range, Zicix can attract more patients and healthcare providers, driving revenue growth over the next five years.
- Telehealth Integration: The integration of telehealth services presents a substantial growth opportunity for Zicix. With the increasing acceptance of telemedicine, particularly post-pandemic, Zicix can leverage this trend by offering remote consultations and diagnostic services. The telehealth market is expected to reach $459.8 billion by 2030, providing Zicix with a chance to tap into a growing patient base and enhance service accessibility.
- Partnerships with Healthcare Providers: Forming strategic partnerships with local hospitals and healthcare providers can significantly boost Zicix's market presence. By collaborating with established healthcare institutions, Zicix can enhance its referral network, leading to increased patient volume. This approach can be particularly effective in the Houston area, where healthcare demand is high and partnerships can yield mutual benefits.
- Adoption of Advanced Imaging Technologies: Investing in cutting-edge imaging technologies such as AI-driven diagnostic tools can position Zicix as a leader in the medical imaging field. The global AI in medical imaging market is expected to grow at a CAGR of 38.4%, reaching $20 billion by 2026. By adopting these technologies, Zicix can improve diagnostic accuracy and efficiency, attracting more patients and healthcare partnerships.
- Market Penetration Strategies: Zicix can implement targeted marketing strategies to increase brand awareness and attract new patients. By focusing on digital marketing and community outreach programs, Zicix can effectively communicate its service offerings and benefits to potential customers. As the healthcare sector becomes increasingly competitive, a robust marketing strategy can drive patient acquisition and retention.
What Are ZICX's Competitive Advantages?
- Specialization in cardiac diagnostic services differentiates Zicix in the healthcare market.
- Established presence in Houston provides a competitive advantage in local markets.
- Diverse range of services enhances patient retention and cross-selling opportunities.
- Focus on innovative treatments like cold laser pain relief positions Zicix as a forward-thinking provider.
- Strong community ties and local reputation can drive patient loyalty and referrals.
What Does ZICX Do?
Founded in 1979, Zicix Corporation, originally known as Bederra Corporation, has evolved significantly over the decades, rebranding itself on February 8, 2011, to reflect its focus on healthcare technology. The company operates primarily through its subsidiary, Texas Mobile Health, Inc., which specializes in providing diagnostic medical imaging services in Houston, Texas. Zicix offers a comprehensive array of cardiac diagnostic services, including echocardiograms, stress testing, carotid ultrasounds, and halter and event monitoring. Additionally, the company provides general medical services such as home health patient care, immigration physicals, weight reduction programs, cold laser pain relief treatments, physical therapy, and anti-aging treatments. The company also delivers advanced imaging services, including MRI, CT, and X-Ray services, catering to a diverse patient demographic. Despite its small size, with only two employees, Zicix Corporation is strategically positioned in the healthcare technology sector, addressing critical diagnostic needs in a growing market. The company's commitment to delivering high-quality medical services reflects its dedication to improving patient outcomes and enhancing healthcare accessibility in its local community.
What Products and Services Does ZICX Offer?
- Provide diagnostic medical imaging services in Houston, Texas.
- Offer cardiac diagnostic services including echocardiograms and stress testing.
- Deliver general medical care and home health patient services.
- Conduct immigration physicals and weight reduction programs.
- Provide advanced imaging services such as MRI, CT, and X-Ray.
- Focus on improving patient outcomes through innovative healthcare solutions.
How Does ZICX Make Money?
- Generate revenue through diagnostic imaging services and medical consultations.
- Charge fees for various medical services including cardiac diagnostics and physicals.
- Leverage partnerships with healthcare providers for patient referrals.
- Implement service packages for home health patients to increase service uptake.
- Focus on expanding service offerings to capture a larger market share.
What Industry Does ZICX Operate In?
The healthcare technology industry is experiencing significant growth, driven by advancements in medical imaging and an increasing demand for diagnostic services. The global medical imaging market is projected to grow at a CAGR of approximately 5.5% from 2021 to 2028, reaching around $48 billion by 2028. Zicix Corporation, operating within this expanding sector, is positioned to benefit from these trends as it provides essential diagnostic services. The competitive landscape includes established players such as Infineon Technologies AG and Constellation Software Inc., which offer various healthcare technology solutions. Zicix's focus on diagnostic imaging services allows it to carve a niche in a crowded market, particularly in the Houston area, where demand for such services is on the rise.
Who Are ZICX's Key Customers?
- Patients seeking diagnostic medical imaging services in Houston.
- Home health patients requiring medical care and consultations.
- Individuals needing immigration physicals and general medical assessments.
- Healthcare providers seeking partnerships for diagnostic services.
- Patients interested in weight reduction and anti-aging treatments.
Company Profile
Zicix Corporation, through its subsidiary Texas Mobile Health, operates in the Software - Application industry within the Technology sector. It is headquartered in Causeway Bay, HK. The company is led by CEO Edwin Kai Ip Li. ZICX has traded publicly since 2009.
Zicix Corporation, through its subsidiary Texas Mobile Health, Financial Trajectory
Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX) reported $432K in revenue for Q4 2025, reflecting 43.6% growth compared to the prior quarter. The company recorded a net loss of $287K, with diluted EPS of $-0.03.
How Zicix Corporation, through its subsidiary Texas Mobile Health, Is Valued
Relative to its peer group, ZICX's quantitative score of 49/100 is roughly in line with the peer average of 57/100.
Key Financial Metrics
Return on equity for Zicix Corporation, through its subsidiary Texas Mobile Health, stands at 53.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -70.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -2.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.39 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -134.9%, the inverse of the P/E and a quick read on earnings relative to price.
Financial Health
Zicix Corporation, through its subsidiary Texas Mobile Health,'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -7.15 places it in the distress zone, a signal of elevated financial risk.
ZICX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Established reputation in Houston for diagnostic medical imaging services.
- Diverse range of medical services catering to various patient needs.
- Strong focus on cardiac diagnostics, a critical healthcare area.
- Ability to leverage advanced imaging technologies for improved patient care.
Bear Case
- Limited workforce with only two employees, restricting operational capacity.
- Negative profit margin indicating financial challenges.
- Small market cap may limit access to capital for expansion.
- Dependence on local market conditions in Houston.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $431,981 | -$286,586 | -$0.03 |
| Q2 2025 | $300,869 | -$189,582 | -$0.10 |
Based on FMP financials and quantitative analysis
ZICX Latest News
No recent news available for ZICX.
ZICX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ZICX.
Price Targets
Wall Street price target analysis for ZICX.
ZICX MoonshotScore
What does this score mean?
The MoonshotScore rates ZICX 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Edwin Kai Ip Li
CEO
Edwin Kai Ip Li has been at the helm of Zicix Corporation, leading the company through its transformation into a healthcare technology provider. With a background in management and healthcare services, he has been instrumental in shaping the company's strategic direction. His leadership has focused on enhancing service offerings and improving operational efficiencies within the organization.
Track Record: Under Edwin's leadership, Zicix has rebranded and refocused its business model to emphasize diagnostic medical imaging services. His strategic decisions have aimed at expanding the company's service offerings and establishing a foothold in the Houston healthcare market.
ZICX OTC Market Information
The OTC Other tier includes companies that trade on the over-the-counter market but do not meet the requirements for higher tiers such as OTCQX or OTCQB. These companies may have limited disclosure requirements and lower trading volumes compared to those listed on major exchanges like NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited financial disclosure may result in a lack of transparency for investors.
- Lower liquidity in OTC markets can lead to price volatility.
- Potential for less regulatory oversight compared to companies listed on major exchanges.
- Increased risk of fraud or misrepresentation in OTC markets.
- Verify the company's financial statements and disclosures.
- Assess the management team's experience and track record.
- Evaluate the competitive landscape and market position.
- Investigate any regulatory risks associated with the company's operations.
- Review customer feedback and satisfaction regarding service offerings.
- Established history since 1979 indicates a level of operational stability.
- Rebranding efforts reflect a strategic focus on healthcare technology.
- Presence in a growing market sector suggests potential for future growth.
ZICX Technology Stock FAQ
What does the AI Score mean for ZICX?
ZICX holds an AI Score of 49/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Zicix Corporation, through its subsidiary Texas Mobile Health, provides diagnostic medical imaging services in Houston, Texas. The company offers a range of medical services including cardiac …
What does Zicix Corporation do?
Zicix Corporation specializes in diagnostic medical imaging services through its subsidiary Texas Mobile Health, located in Houston, Texas. The company offers a range of services including cardiac diagnostics, general medical care, and advanced imaging such as MRI and CT scans. By focusing on these essential healthcare services, Zicix aims to improve patient outcomes and enhance accessibility to medical diagnostics in the community.
What are the growth drivers for ZICX stock?
Zicix Corporation's primary growth drivers include the expansion of its diagnostic services, particularly in cardiac care, and the integration of telehealth solutions. The increasing demand for medical imaging services, driven by an aging population and advancements in technology, positions Zicix to capture market share. Additionally, strategic partnerships with local healthcare providers can enhance patient referrals and service delivery, contributing to revenue growth.
What are the main risks for ZICX?
Zicix Corporation faces several risks, including intense competition from established healthcare providers, which may limit market share growth. Additionally, economic downturns can affect patient spending on healthcare services, impacting revenue. Regulatory changes in the healthcare sector may also pose challenges, affecting operational costs and service delivery. Furthermore, the company's dependence on local market conditions in Houston could expose it to regional economic fluctuations.
What are the key factors to evaluate for ZICX?
Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX) holds an AI score of 49/100 (low). Zicix Corporation presents a unique investment thesis characterized by its specialized focus on diagnostic medical imaging services, which are critical in today's healthcare landscape. Not financial advice.
How frequently does ZICX data refresh on this page?
ZICX's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ZICX's recent stock price performance?
Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established reputation in Houston for diagnostic medical imaging services. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ZICX overvalued or undervalued right now?
Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ZICX before investing?
Before investing in Zicix Corporation, through its subsidiary Texas Mobile Health, (ZICX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available due to OTC classification.